Recovery act establishing a small molecule chemical repository for the NCI chemical biology consortium
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201000079C
- Awardee
-
Evotec US Inc. UEI LA7FUVX1EZQ7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,440,013
Award facts
- Opportunity
-
- HHSN261201000079C Solicitation number
- Contract value 93% obligated
-
- $5,440,282.82 Current, with exercised options
- $5,837,230.82 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$43,506 | |
| Funding Only Action | $43,473 | |
| Exercise an Option | $440,691 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Novation Agreement | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,999,355 |
About this award
This federal contract award to Evotec US Inc., a foreign-owned for-profit organization, was made by the National Cancer Institute (NCI) to establish a small molecule chemical repository for the NCI Chemical Biology Consortium. The $5,837,230.82 cost-plus-fixed-fee definitive contract has a period of performance through September 29, 2015 and does not utilize any set-aside designations. Evotec specializes in chemical procurement, analysis, sample preparation, and management services, and has a history of providing similar support to civilian federal agencies like the Environmental Protection Agency (EPA). This contract aligns with Evotec's expertise and past performance supporting federal research and development programs, particularly in the areas of chemical screening and environmental research.
Quick answers
Who was awarded contract HHSN261201000079C?
HHSN261201000079C was awarded to Evotec US Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2010.
How much is contract HHSN261201000079C worth?
The government has obligated $5,440,013 on HHSN261201000079C. Its current value, with exercised options, is $5,440,283. Its potential value, with all options, is $5,837,231.
Was contract HHSN261201000079C competed?
The extent of competition for HHSN261201000079C was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award